| Author | Number and range of age | Intervention (herbal medicine and acupoints) and duration | Outcomes | Adverse events (experimental) | Jadad score | Experimental | Control | Experimental | Control |
| Zhu 2010 [23] | 47/5–55 | 44/8–50 | San-Fu-Tie, for one year | Cetirizine and beclometasone dipropionate aqueous nasal spray, for ten consecutive days | Efficacy evaluation | Not mentioned | 2 | Bai Jie Zi, Xi Xin, Gan Sui, Yan Hu Suo, Ban Xia | GV14, BL20, CV17, BL12, BL13, BL23 |
|
Chen and Gu 2011 [24] | 40/4–7 | 34/4–7 | San-Fu-Tie, for two-three consecutive years | Oxymetazoline hydrochloride spray and dexamethasone, withdrawal when symptomatic relief occurs | Efficacy evaluation | Not mentioned | 2 | Bai Jie Zi, Xi Xin, Ma Huang, Xin Yi, Sheng Jiang | GV14, BL13, BL43, PC6 |
| Lin et al. 2014 [19] | 84/5–82 | 84/5–82 | San-Fu-Tie, four times a year (dog days are four ten-day periods in 2013), for one year | Beclometasone dipropionate aqueous nasal spray, for four weeks | Efficacy evaluation, symptom rating scale | Not mentioned | 4 | Bai Jie Zi, Xi Xin, Ma Huang, Gan Sui, Yan Hu Suo, Ding Xiang, Sheng Jiang | BL13, BL20, GV14, BL23, BL12, LI4, EX-B1, ST36, EX-HN15 |
|
|
Bai Jie Zi, Semen Sinapis Albae; Xi Xin, Herba Asari; Gan Sui, Radix Kansui; Yan Hu Suo, Rhizoma Corydalis; Sheng Jiang, Rhizome Zingiberis Recens; Ban Xia, Rhizoma Pinelliae; Ma Huang, Herba Ephedrae; Xin Yi, Flos Magnoliae; Ding Xiang, Flos Caryophylli. BL13, Feishu; BL43, Gaohuang; EX-HN15, Bailao; CV17, Danzhong; EX-B1, Dingchuan; GV14, Dazhui; BL20, Pishu; BL12, Fengmen; BL23, Shenshu; PC6, Neiguan; LI4, Hegu; ST36, Zusanli. AR, allergic rhinitis; cAMP, cyclic Adenosine Monophosphate; cGMP, cyclic Guanosine Monophosphate.
|